Showing results (51-60 of 189) with videos related to

Sort By:
Pageof 19
Autoimmunity Reviews|September 1, 2009
Current status on B-cell depletion therapy in autoimmune diseases other than rheumatoid arthritisThomas Dörner, David Isenberg, David Jayne, et al.
The Lancet. Haematology|August 1, 2020
Management of anticoagulant-refractory thrombotic antiphospholipid syndromeHannah Cohen, Zara Sayar, Maria Efthymiou, et al.
Rheumatology (Oxford, England)|April 22, 2022
Major determinants of prolonged remission in systemic lupus erythematosus: retrospective study over a 41+ year periodGoncalo Durao-Carvalho, Raquel Fernández-González, Bethan Goulden, et al.
Arthritis Care & Research|November 12, 2015
Analysis of Complete Remission in Systemic Lupus Erythematosus Patients Over a 32-Year PeriodCarmen V Medina-Quiñones, Lucía Ramos-Merino, Pablo Ruiz-Sada, et al.
Expert Opinion on Biological Therapy|April 7, 2026
The role of monoclonal antibodies in the treatment of lupus nephritisUxía Couto-Lareo, Blanca Viejo-Sosa, Mònica Angerri-Nadal, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|July 9, 2016
Post Hoc Analysis of the Phase II/III APRIL-SLE Study: Association Between Response to Atacicept and Serum Biomarkers Including BLyS and APRILCaroline Gordon, David Wofsy, Stephen Wax, et al.
Rheumatology (Oxford, England)|November 22, 2020
Fracture risk in systemic lupus erythematosus patients over 28 yearsDaniela Garelick, Sara Moreira Pinto, Filipa Farinha, et al.
Drug Discovery Today|June 26, 2016
Optimising B-cell depletion in autoimmune disease: is obinutuzumab the answer?Venkat Reddy, Lekh N Dahal, Mark S Cragg, et al.
Arthritis Research & Therapy|January 12, 2005
The critical role of arginine residues in the binding of human monoclonal antibodies to cardiolipinIan Giles, Nancy Lambrianides, David Latchman, et al.
Pageof 19